A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
INTRODUCTION[|]This study aims to compare the efficacy of intravitreal injection of aflibercept (IVA), ranibizumab (IVR) and dexamethasone implant (DEX IMP) for the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO).[¤]METHODS[|]In this retrospective and comparative st...
Main Authors: | Alper Halil Bayat, Selim Bölükbaşı, Burak Erden, Akin Cakir, Şeyma Gülcenur Özturan, Mehmet Tayfur, Mustafa Nuri Elcioglu |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-12-01
|
Series: | Beyoglu Eye Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-18291 |
Similar Items
-
Visual recovery comes after anatomical recovery after intravitreal aflibercept treatment in macular edema secondary to branch retinal vein occlusion
by: Alper Halil Bayat, et al.
Published: (2018-12-01) -
Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion
by: Alper Halil Bayat, et al.
Published: (2018-09-01) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01) -
Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
by: Makri OE, et al.
Published: (2018-09-01) -
Efficacy of intravitreal injection of Aflibercept vs Ranibizumab in the treatment of diabetic retinopathy
by: Chang Huang, et al.
Published: (2021-05-01)